Skip to main content

Table 3 Psychiatric status

From: Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines

Group of patients

Treated with haloperidol

(n = 30)

Treated with olanzapine

(n = 30)

Visit number

V1

V2

V3

V1

V2

V3

PANSS Total scores (mean ± sd)

91.4 ± 13.6

79.6 ± 14.7

73.5 ± 17.3

87.4 ± 18.9

72.1 ± 19.0

63.8 ± 19.3

CGI-S scores (mean ± sd)

5.4 ± 0.8

4.6 ± 0.9

4.04 ± 1.04

5.1 ± 0.9

4.14 ± 1.1

3.5 ± 1.1

CGI-I scores (mean ± sd)

3.0 ± 0.7

2.8 ± 0.9

2.89 ± 0.9

2.8 ± 1.1

SAS scores (mean ± sd)

0.17 ± 0.54

4.8 ± 4.14

6.6 ± 4.37

0.07 ± 0.26

0.96 ± 1.86

0.85 ± 1.5

ESRS scores (mean ± sd)

0.4 ± 1.42

18.1 ± 14.9

22.6 ± 14.9

0.45 ± 2.4

3.5 ± 5.3

3.2 ± 5.2

  1. sd – standard deviation
  2. PANSS – Positive and Negative Syndrome Scale for Schizophrenia
  3. CGI-S – Clinical Global Impression of Severity
  4. CGI-I – Clinical Global Impression of Improvement
  5. SAS – Simpson-Angus Scale for Extrapyramidal Symptoms
  6. ESRS – Extrapyramidal Rating Scale